Sentence examples for bid achieved from inspiring English sources

However, this time, amoxicillin-clavulanate in both dosing formulations (500/125 mg TID and 875/125 mg BID) achieved above 90% CFR for all pathogens.

A significantly greater proportion of patients receiving apremilast 20 mg BID and 30 mg BID achieved DAS-28 (CRP) remission (<2.6) compared with placebo.

In ESTEEM 2, 70.8 % of patients receiving apremilast 30 mg BID achieved a ≥5-point improvement in DLQI at 16 weeks, versus 42.9%% of those receiving placebo (p < 0.0001) [ 16].

In an open-label, phase II study (n = 30), 46.7 % of patients treated with apremilast 20 mg BID achieved PASI-50, 30.0 % achieved PASI-75, and 13.3 % achieved PASI-90 (a mean improvement of 59.0 %) at week 12.

A significantly greater proportion of patients receiving exenatide QW compared with patients receiving exenatide BID achieved target HbA1c levels of <7% (77% vs 61%, P = 0.0039), with no increased risk of hypoglycemia.

We asked next whether increase of the cellular level of BID achieved due to controlled delivery of the protein resulted in increased sensitivity of PC3 cells to apoptosis induced by TRAIL.

The voting is conducted in a succession of rounds until one bid achieves an absolute majority of votes; if this does not happen in the first round, the bid with the fewest votes is eliminated and another voting round begins.

The top numbers here still greatly trail behind the blue-chip success of the male masters; at the same Sotheby's sale that de Lempicka achieved her top price, Egon Schiele broke his world record with a £24,681,250 bid, achieving the third highest sale of the year so far.

Even at very high doses of NFV (3,125 mg bid), Akt achieved a level of inhibition around 55% in cell culture.

The evidences that support these conclusions are: 1) Even at very high doses of NFV (3,125 mg bid), Akt achieved a level of inhibition around 55% in cell culture.

The 150 mg bid dose showed superior efficacy to warfarin for the primary endpoint of stroke or systemic embolism [1.11 vs. 1.71% per year; RR 0.65 (95% CI 0.52 0.81); P< 0.001 for superiority], and the 110 mg bid dose achieved non-inferiority [1.54 vs. 1.71% per year; RR 0.90 (95% CI 0.74 1.10); P< 0.001 for non-inferiority], but not superiority (Table  3 ).